Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The sportdiet study

dc.contributor.authorBerzigotti, Annalisa
dc.contributor.authorAlbillos, Agustín
dc.contributor.authorVillanueva, Càndid
dc.contributor.authorGenescà, Joan
dc.contributor.authorArdevol, Alba
dc.contributor.authorAugustin, Salvador
dc.contributor.authorCalleja Panero, José Luis
dc.contributor.authorBañares, Rafael
dc.contributor.authorGarcía Pagán, Juan Carlos
dc.contributor.authorMesonero, Francisco
dc.contributor.authorBosch i Genover, Jaume
dc.contributor.authorCiberehd SportDiet Collaborative Group
dc.date.accessioned2019-02-06T11:59:30Z
dc.date.available2019-02-06T11:59:30Z
dc.date.issued2017-04
dc.date.updated2019-02-06T11:59:30Z
dc.description.abstractObesity increases the risk of clinical decompensation in cirrhosis, possibly by increasing portal pressure. Whether weight reduction can be safely achieved through lifestyle (LS) changes (diet and exercise) in overweight/obese patients with cirrhosis, and if weight loss reduces portal pressure in this setting, is unknown. This prospective, multicentric, uncontrolled pilot study enrolled patients with compensated cirrhosis, portal hypertension (hepatic venous pressure gradient [HVPG] ≥6 mm Hg), and body mass index (BMI) ≥26 kg/m2 in an intensive 16‐week LS intervention program (personalized hypocaloric normoproteic diet and 60 min/wk of supervised physical activity). We measured HVPG, body weight (BW) and composition, adipokines, health‐related quality of life, and safety data before and after the intervention. Changes in HVPG and BW were predefined as clinically relevant if ≥10% and ≥5%, respectively. Safety and BW were reassessed after 6 months. 60 patients were included and 50 completed the study (56 ± 8 years old; 62% male; nonalcoholic steatohepatitis etiology 24%; BMI 33.3 ± 3.2 kg/m2; Child A 92%; HVPG ≥10 mm Hg, 72%). LS intervention significantly decreased BW (average, -5.0 ± 4.0 kg; P < 0.0001), by ≥5% in 52% and ≥10% in 16%. HVPG also significantly decreased (from 13.9 ± 5.6 to 12.3 ± 5.2 mm Hg; P < 0.0001), by ≥10% in 42% and ≥20% in 24%. A ≥10% BW loss was associated with a greater decrease in HVPG (-23.7 ± 19.9% vs. -8.2 ± 16.6%; P = 0.024). No episodes of clinical decompensation occurred. Weight loss achieved at 16 weeks was maintained at 6 months; Child and Model for End‐Stage Liver Disease scores did not change. Conclusion: Sixteen weeks of diet and moderate exercise were safe and reduced BW and portal pressure in overweight/obese patients with cirrhosis and portal hypertension.
dc.format.extent13 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec669680
dc.identifier.issn0270-9139
dc.identifier.pmid27997989
dc.identifier.urihttps://hdl.handle.net/2445/127960
dc.language.isoeng
dc.publisherWiley
dc.relation.isformatofVersió postprint del document publicat a: https://doi.org/10.1002/hep.28992
dc.relation.ispartofHepatology, 2017, vol. 65, num. 4, p. 1293-1305
dc.relation.urihttps://doi.org/10.1002/hep.28992
dc.rights(c) American Association for the Study of Liver Diseases, 2017
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationCirrosi hepàtica
dc.subject.classificationObesitat
dc.subject.classificationHipertensió
dc.subject.otherHepatic cirrhosis
dc.subject.otherObesity
dc.subject.otherHypertension
dc.titleEffects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The sportdiet study
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
669680.pdf
Mida:
1.69 MB
Format:
Adobe Portable Document Format